Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 810 | 904 | 1,160 | 2,081 | 3,040 |
| Operating Income | -810 | -904 | -1,160 | -2,081 | -3,040 |
| Other Income | 26 | 38 | -390 | 161 | 1,271 |
| Pre-tax Income | -784 | -866 | -1,550 | -1,920 | -1,769 |
| Net Income Continuous | -784 | -866 | -1,550 | -1,920 | -1,769 |
| Net Income | $-784 | $-866 | $-1,550 | $-1,920 | $-1,769 |
| EPS Basic Total Ops | -4.02 | -7.86 | 187.76 | -29.39 | -31.25 |
| EPS Basic Continuous Ops | -4.02 | -7.86 | 187.81 | -29.39 | -31.31 |
| EPS Diluted Total Ops | -4.02 | -7.86 | 187.76 | -29.39 | -31.25 |
| EPS Diluted Continuous Ops | -4.02 | -7.86 | 187.81 | -29.39 | -31.31 |
| EPS Diluted Before Non-Recurring Items | -4.02 | -7.86 | N/A | N/A | N/A |
| EBITDA(a) | $-810 | $-904 | $-1,160 | $-2,081 | $-3,040 |